オンコセルカ症(河川盲目症)(Onchocerciasis (River Blindness)):世界の治験レビュー2014年下半期版...市場調査レポートについてご紹介

【英文タイトル】Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Onchocerciasis (River Blindness) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Onchocerciasis (River Blindness) to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Onchocerciasis (River Blindness) to Infectious Disease Clinical Trials 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Onchocerciasis (River Blindness) 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Onchocerciasis (River Blindness) Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Pfizer Inc. 29
Clinical Trial Overview of Pfizer Inc. 29
Johnson & Johnson 30
Clinical Trial Overview of Johnson & Johnson 30
Clinical Trial Overview of Top Institutes / Government 31
Liverpool School of Tropical Medicine 31
Clinical Trial Overview of Liverpool School of Tropical Medicine 31
Washington University School of Medicine 32
Clinical Trial Overview of Washington University School of Medicine 32
UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases 33
Clinical Trial Overview of UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases 33
University of California, San Francisco 34
Clinical Trial Overview of University of California, San Francisco 34
The National Institute of Allergy and Infectious Diseases 35
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 35
University Hospitals Case Medical Center 36
Clinical Trial Overview of University Hospitals Case Medical Center 36
European Commission 37
Clinical Trial Overview of European Commission 37
Case Western Reserve University 38
Clinical Trial Overview of Case Western Reserve University 38
Centers for Disease Control and Prevention 39
Clinical Trial Overview of Centers for Disease Control and Prevention 39
University of Medicine and Dentistry New Jersey (Inactive) 40
Clinical Trial Overview of University of Medicine and Dentistry New Jersey (Inactive) 40
Five Key Clinical Profiles 41
Appendix 58
Abbreviations 58
Definitions 58
Research Methodology 59
Secondary Research 59
About GlobalData 60
Contact Us 60
Disclaimer 60
Source 60


【レポート販売概要】

■ タイトル:オンコセルカ症(河川盲目症)(Onchocerciasis (River Blindness)):世界の治験レビュー2014年下半期版
■ 英文:Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014
■ 発行日:2014年12月31日
■ 調査会社:GlobalData
■ 商品コード:GDHC2487CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。